Cover Image
Market Research Report

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 557881
Published Content info 130 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2019-2023
Published: June 17, 2019 Content info: 130 Pages
Description

About this market

Human immunodeficiency virus rapid test kits are used for the detection of HIV antibodies present in the body. The HIV rapid tests provide results in few minutes, thereby eliminating the need for longer waiting period. Technavio's human immunodeficiency virus rapid test kits market analysis considers the revenue generation based on end-users that includes diagnostic centers, and hospitals and clinics. Our analysis also considers the sales of human immunodeficiency virus rapid test kits in North America, Europe, Asia, and ROW. In 2018, the diagnostic centers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing awareness about the benefits of early detection play a significant role in the diagnostic centers segment to maintain their market position. Also, our global human immunodeficiency virus rapid test kits market report looks at factors such as the rise in awareness programs for HIV testing, growing demand for point-of-care testing for HIV, and the high prevalence of HIV. However, the non-availability of rapid HIV products in limited resource settings, limited healthcare services in developing regions, and lack of trained professionals may hamper the growth of the human immunodeficiency virus rapid test kits industry over the forecast period.

Overview

Growing demand for point-of-care testing for HIV

The demand for point-of-care testing for HIV is increasing at a significant rate as POC testing technologies are affordable and easily accessible. Point-of-care testing can also detect HIV at an early stage, which is essential to start primary treatment and prevent the onset of AIDS. Thus, the growing demand for point-of-care testing for HIV will fuel the growth of the HIV test kits market at a CAGR of more than 7% during the forecast period.

Availability of a broad range of HIV rapid test kits by vendors

Vendors in the market are increasingly focusing on manufacturing innovative test kits to cater to the growing demand for HIV testing. The demand is increasing mainly driven by a paradigm shift from treatment to the preventive healthcare system. Thus, the availability of a broad range of HIV rapid test kits by vendors is identified as a key HIV test kits market trends that will fuel the growth of the market during the forecast period.

For the detailed list of factors that will drive the global human immunodeficiency virus rapid test kits market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of few major players, the global human immunodeficiency virus rapid test kits market is moderately concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading HIV test kits manufacturers, that include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., and QIAGEN Group.

Also, the human immunodeficiency virus rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Table of Contents
Product Code: IRTNTR31494

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Diagnostic centers - Market size and forecast 2018-2023
  • Hospitals and clinics - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY TYPE

  • HIV rapid immunoassay test
  • HIV rapid molecular diagnostic test

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Efforts to increase pre-marital screenings for HIV
  • Increasing clinical studies by researchers and promotional
  • activities by manufacturers
  • Availability of a broad range of HIV rapid test kits by vendors

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN Group

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Diagnostic centers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Diagnostic centers - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Hospitals and clinics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Hospitals and clinics - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by end-user
  • Exhibit 24: Customer landscape
  • Exhibit 25: Market share of global human immunodeficiency virus (HIV) rapid test kits market by test type 2018
  • Exhibit 26: Market share by geography 2018-2023 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Abbott Laboratories - Vendor overview
  • Exhibit 45: Abbott Laboratories - Business segments
  • Exhibit 46: Abbott Laboratories - Organizational developments
  • Exhibit 47: Abbott Laboratories - Geographic focus
  • Exhibit 48: Abbott Laboratories - Segment focus
  • Exhibit 49: Abbott Laboratories - Key offerings
  • Exhibit 50: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 51: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 52: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 53: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 54: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 55: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 56: Danaher Corp. - Vendor overview
  • Exhibit 57: Danaher Corp. - Business segments
  • Exhibit 58: Danaher Corp. - Organizational developments
  • Exhibit 59: Danaher Corp. - Geographic focus
  • Exhibit 60: Danaher Corp. - Segment focus
  • Exhibit 61: Danaher Corp. - Key offerings
  • Exhibit 62: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 63: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 64: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 65: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 66: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 67: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 68: QIAGEN Group - Vendor overview
  • Exhibit 69: QIAGEN Group - Product segments
  • Exhibit 70: QIAGEN Group - Organizational developments
  • Exhibit 71: QIAGEN Group - Geographic focus
  • Exhibit 72: QIAGEN Group - Segment focus
  • Exhibit 73: QIAGEN Group - Key offerings
  • Exhibit 74: Validation techniques employed for market sizing
  • Exhibit 75: Definition of market positioning of vendors
Back to Top